In 1998, ICE began an extensive product development effort with a leading provider of technologies for single nucleotide polymorphism (SNP) scoring and genetic diversity analyses.
Our engineers assisted with the development of proprietary technology for instruments and SNPware consumables. This technology allowed SNP information to be generated quickly and accurately. The software coordinates with analysis equipment in environments ranging from small-scale laboratories to large commercial facilities.
"The team at ICE did a fantastic job for us during a critical time of software development. Their close interaction with our program coordinator helped to sustain efficiency throughout development. Their grasp of biotechnology was sufficient to help them drive the program. Their integrity is absolutely solid. I would not hesitate to use them again in mission-critical development programs."
Dale Pfost, Ph.D., Chairman, President and CEO of Acuity Pharma, formerly Chairman and CEO of Orchid Biosciences.
Dale Pfost, Ph.D., Chairman, President and CEO of Acuity Pharma, formerly Chairman and CEO of Orchid Biosciences.
Our expertise includes a detailed understanding of genetics and bioinformatic operations, sequence analysis, sequence alignment and other tools used to access the public genomic databases.
ICE designs software tools for Bioinformatics R&D:- High throughput SNP scoring services
- SNP databases
- Genetic diversity
- Microfluidics technologies relating to drug discovery
- Pharmacogenetics and DNA synthesis